Constitutive AKT Activity Predisposes Lung Fibrosis by Regulating Macrophage, Myofibroblast and Fibrocyte Recruitment and Changes in Autophagy

Abstract

The etiology and pathogenesis of pulmonary fibrosis is poorly understood. We and others reported that M-CSF/CSF-1, M-CSF-R and downstream AKT activation plays an important role in lung fibrosis in mice models and in IPF patients. To understand potential molecular pathways used by M-CSF-R activation to direct lung fibrosis, we used a novel transgenic mouse model that expresses a constitutively-active form of AKT, myristoylated AKT (Myr- Akt ), driven by the c-fms (M-CSF-R) promoter. We were particularly interested in the basal immune state of the lungs of these Myr- Akt mice to assess M-CSF-R-related priming for lung fibrosis. In support of a priming effect, macrophages isolated from the lungs of unchallenged Myr- Akt mice displayed an M2-tropism, enhanced co-expression of M-CSF-R and α -SMA, re duced autophagy reflected by reduced expression of the key autophagy genes Beclin -1, MAP1- Lc 3 a ( Lc 3 a ) , and MAP1- Lc 3 b ( Lc 3 b ) , and increased p 62/ STSQM 1 expression compared with littermate WT mice. Furthermore, Myr- Akt mice had more basal circulating fibrocytes than WT mice. Lastly, upon bleomycin challenge, Myr- Akt mice showed enhanced collagen deposition, increased F4/80+ and CD45+ cells, reduced autophagy genes Beclin -1, Lc 3 a , and Lc 3 b expression, and a shorter life-span than WT littermates. These data provide support that M-CSF-R/AKT activation may have a priming effect which can predispose lung tissue to pulmonary fibrosis .